ATE10940T1 - Pyrrolderivate. - Google Patents
Pyrrolderivate.Info
- Publication number
- ATE10940T1 ATE10940T1 AT82302337T AT82302337T ATE10940T1 AT E10940 T1 ATE10940 T1 AT E10940T1 AT 82302337 T AT82302337 T AT 82302337T AT 82302337 T AT82302337 T AT 82302337T AT E10940 T1 ATE10940 T1 AT E10940T1
- Authority
- AT
- Austria
- Prior art keywords
- formula
- optionally substituted
- benzo
- ring
- pyrrol derivatives
- Prior art date
Links
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical class C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 title 1
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical class C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 abstract 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical class C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 abstract 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical class N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 abstract 2
- 102000016912 Aldehyde Reductase Human genes 0.000 abstract 1
- 108010053754 Aldehyde reductase Proteins 0.000 abstract 1
- 208000027472 Galactosemias Diseases 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003233 pyrroles Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8114402 | 1981-05-12 | ||
| EP82302337A EP0065393B1 (de) | 1981-05-12 | 1982-05-07 | Pyrrolderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE10940T1 true ATE10940T1 (de) | 1985-01-15 |
Family
ID=10521725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT82302337T ATE10940T1 (de) | 1981-05-12 | 1982-05-07 | Pyrrolderivate. |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4443465A (de) |
| EP (1) | EP0065393B1 (de) |
| JP (1) | JPS57192386A (de) |
| AT (1) | ATE10940T1 (de) |
| DE (1) | DE3261684D1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4533667A (en) * | 1983-05-25 | 1985-08-06 | Pfizer Inc. | Imidazolidinedione derivatives |
| JPS6317886A (ja) * | 1986-07-11 | 1988-01-25 | Kyorin Pharmaceut Co Ltd | スピロピロリジン−２，５−ジオン誘導体の製法 |
| JPS6317885A (ja) * | 1986-07-11 | 1988-01-25 | Kyorin Pharmaceut Co Ltd | スピロピロリジン−２，５−ジオン誘導体の製造方法 |
| GB0907601D0 (en) * | 2009-05-01 | 2009-06-10 | Equateq Ltd | Novel methods |
| ES2755719T3 (es) * | 2012-04-05 | 2020-04-23 | Nerviano Medical Sciences Srl | Nuevos agentes alquilantes |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4117230A (en) * | 1976-10-18 | 1978-09-26 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| US4127665A (en) * | 1978-01-18 | 1978-11-28 | Pfizer Inc. | Thienohydantoin derivatives |
| US4181728A (en) * | 1978-11-16 | 1980-01-01 | Pfizer Inc. | Spiro-polycyclicimidazolidinedione derivatives |
| US4176185A (en) * | 1979-01-22 | 1979-11-27 | Pfizer Inc. | Spiro-quinolylhydantoins |
| US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
-
1982
- 1982-05-07 AT AT82302337T patent/ATE10940T1/de not_active IP Right Cessation
- 1982-05-07 EP EP82302337A patent/EP0065393B1/de not_active Expired
- 1982-05-07 DE DE8282302337T patent/DE3261684D1/de not_active Expired
- 1982-05-11 US US06/377,133 patent/US4443465A/en not_active Expired - Lifetime
- 1982-05-12 JP JP57079797A patent/JPS57192386A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPS57192386A (en) | 1982-11-26 |
| DE3261684D1 (en) | 1985-02-07 |
| EP0065393B1 (de) | 1984-12-27 |
| US4443465A (en) | 1984-04-17 |
| EP0065393A1 (de) | 1982-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0620215T3 (da) | 1H-indol-3-acetamidderivater som sPLA2-inhibitorer | |
| DE3262294D1 (en) | Pharmaceutical compositions containing spiro succinimide derivatives | |
| NO822799L (no) | Fremgangsmaate ved fremstilling av 6alfa-methylprednisolon-derivater. | |
| RU1799379C (ru) | Способ получени замещенных производных индола, бензофурана или бензотиофена | |
| ES2077071T3 (es) | Derivados de quinolin-3-carboxamida. | |
| ATE10940T1 (de) | Pyrrolderivate. | |
| AU5636880A (en) | Indole derivatives | |
| IE782185L (en) | Isothiazole derivatives | |
| AU6594900A (en) | Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof andagents | |
| IE812439L (en) | Pyrano £2,3| pyrroles | |
| ES473680A1 (es) | Metodo para la produccion de azaxantonas y sus derivados. | |
| AU541190B2 (en) | Cephalosporin derivatives | |
| ZA812541B (en) | Benzothiazole derivatives and salts thereof,processes for their preparation,and their use as sweetening agents | |
| ATE259800T1 (de) | Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate | |
| DK460783A (da) | 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxider, fremgangsmaade til deres fremstilling samt deres anvendelse | |
| JPS5416467A (en) | Pyrrole derivative |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |